PB2144: TRIAL IN PROGRESS: A PHASE 1/2 WINDOW OF OPPORTUNITY STUDY OF THE BCMAXCD3 BISPECIFIC ANTIBODY LINVOSELTAMAB IN PREVIOUSLY UNTREATED PATIENTS WITH SYMPTOMATIC MULTIPLE MYELOMA

Detalles Bibliográficos
Autores principales: Ferreri, Christopher J., Quatela, Steven, Aina, Oluwaseun, Roy, Pourab, Boyapati, Anita, Lorenc, Karen Rodriguez, Kroog, Glenn, Orlowski, Robert Z
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Publication Only
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429554/
http://dx.doi.org/10.1097/01.HS9.0000975336.52123.51

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429554/
http://dx.doi.org/10.1097/01.HS9.0000975336.52123.51

Ejemplares similares